Nigeria Cuts Malaria Rate in Half Since 2010

Nigeria is winning its fight against one of the world's deadliest diseases, and the numbers prove it.

The World Health Organization announced that Nigeria has more than halved its malaria prevalence since 2010, dropping from 42% to 22% by 2021 and continuing to fall. Dr. Lynda Ozor, WHO's Malaria Programme Manager, called the trend proof that Nigeria is taking malaria control seriously through integrated strategies.

The progress comes from a combination of expanded insecticide-treated mosquito nets, seasonal prevention programs for children, and improved diagnosis and treatment services. Strengthened disease tracking systems help health workers identify and respond to outbreaks faster than ever before.

Nigeria began rolling out a new malaria vaccine in 2024, starting in Kebbi and Bayelsa states before expanding to Bauchi. The vaccine requires four doses given at 5, 6, 7, and 15 months as part of routine childhood immunizations.

Some parents have worried about vaccine safety, but Dr. Ozor emphasized that WHO only recommends vaccines after rigorous scientific testing. The RTSS malaria vaccine underwent 34 years of research and extensive trials before approval, and Nigeria's own regulatory agency conducted independent safety reviews.

Side effects are mild and similar to other vaccines, typically just minor headaches. Most communities have actually welcomed the vaccine enthusiastically after waiting years for this breakthrough.

The Ripple Effect

This progress means thousands of Nigerian children who might have gotten sick or died from malaria are now growing up healthy. Families spend less money treating preventable illness and more time working, studying, and building futures.

The decline also reduces strain on Nigeria's healthcare system, freeing up resources to tackle other health challenges. As more children receive protection through nets, medications, and now vaccines, the entire community benefits from fewer mosquitoes carrying the disease.

Dr. Kolawole Maxwell from Malaria Consortium pointed out that reaching every eligible child will determine how much impact the vaccine ultimately delivers. The country's phased rollout approach allows health workers to learn and improve distribution before expanding nationwide.

Malaria still kills over 600,000 people globally each year, mostly African children under five. Nigeria's sustained progress shows that even the toughest health challenges can be overcome with the right tools, commitment, and coordination.

A disease that once infected nearly half of Nigerians is steadily losing ground.